| scholarly article | Q13442814 |
| P356 | DOI | 10.3899/JRHEUM.130365 |
| P698 | PubMed publication ID | 23950188 |
| P2093 | author name string | Johan Frostegård | |
| Ingiäld Hafström | |||
| Sofia Ajeganova | |||
| Maria L E Andersson | |||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | circulatory system | Q11068 |
| rheumatoid arthritis | Q187255 | ||
| P304 | page(s) | 1958-1966 | |
| P577 | publication date | 2013-08-15 | |
| P1433 | published in | The Journal of Rheumatology | Q7743623 |
| P1476 | title | Disease factors in early rheumatoid arthritis are associated with differential risks for cardiovascular events and mortality depending on age at onset: a 10-year observational cohort study | |
| P478 | volume | 40 |
| Q90354326 | A Swedish register-based, long-term inception cohort study of patients with rheumatoid arthritis - results of clinical relevance |
| Q40117130 | Anticitrullinated protein antibodies and rheumatoid factor are associated with increased mortality but with different causes of death in patients with rheumatoid arthritis: a longitudinal study in three European cohorts |
| Q37054390 | Association of HLA-DRB1 haplotypes with rheumatoid arthritis severity, mortality, and treatment response |
| Q92034749 | Autoantibodies and B Cells: The ABC of rheumatoid arthritis pathophysiology |
| Q33879759 | Cardiovascular disease in immune-mediated inflammatory diseases: A cross-sectional analysis of 6 cohorts |
| Q28082992 | Cardiovascular disease risk scores in the current practice: which to use in rheumatoid arthritis? |
| Q38757421 | Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force |
| Q89227766 | Effects of antirheumatic drug underutilization on rheumatoid arthritis disease activity |
| Q26748085 | Effects of tofacitinib and other DMARDs on lipid profiles in rheumatoid arthritis: implications for the rheumatologist |
| Q50911616 | Frequency of methotrexate intolerance in rheumatoid arthritis patients using methotrexate intolerance severity score (MISS questionnaire). |
| Q31149663 | Gender-associated comorbidities in rheumatoid arthritis and their impact on outcome: data from GENIRA. |
| Q39473004 | Hospitalizations for Acute Myocardial Infarction Are Decreased Among Patients with Inflammatory Bowel Disease Using a Nationwide Inpatient Database. |
| Q37156561 | Impact of disease activity and treatment of comorbidities on the risk of myocardial infarction in rheumatoid arthritis |
| Q36932166 | Is preclinical autoimmunity benign?: The case of cardiovascular disease |
| Q58567872 | Lipids and Atherogenic Indices Fluctuation in Rheumatoid Arthritis Patients on Long-Term Tocilizumab Treatment |
| Q64283956 | Mechanisms of hypertension in autoimmune rheumatic diseases |
| Q50533824 | Pentraxin 3 in serum and synovial fluid of patients with rheumatoid arthritis with and without autoantibodies. |
| Q51572553 | Preserved cardiorespiratory function and NT-proBNP levels before and during exercise in patients with recent onset of rheumatoid arthritis: the clinical challenge of stratifying the patient cardiovascular risks. |
| Q50459904 | Red cell distribution width is associated with cardiovascular risk and disease parameters in rheumatoid arthritis. |
| Q41617609 | Risk factors for the rapid increase in risk of acute coronary events in patients with new-onset rheumatoid arthritis: a nested case-control study |
| Q44791359 | Safety and feasibility of maximal physical testing in rheumatic diseases: a cross-sectional study with 5,910 assessments |
| Q47574484 | Stroke among Rheumatoid Arthritis Patients: Does Age Matter A Real-Life Study |
| Q41514844 | Subcutaneous nodules are associated with cardiovascular events in patients with rheumatoid arthritis: results from a large US registry |
| Q28073436 | Targeting Low Disease Activity in Elderly-Onset Rheumatoid Arthritis: Current and Future Roles of Biological Disease-Modifying Antirheumatic Drugs |
| Q39078542 | The effect of rheumatoid arthritis-associated autoantibodies on the incidence of cardiovascular events in a large inception cohort of early inflammatory arthritis |
| Q35092457 | The impact of traditional cardiovascular risk factors on cardiovascular outcomes in patients with rheumatoid arthritis: a systematic review and meta-analysis. |
| Q47175104 | Weight Change During the Early Rheumatoid Arthritis Period and Risk of Subsequent Mortality in Women With Rheumatoid Arthritis and Matched Comparators |
| Q56964268 | [Long-term glucocorticoid therapy : Is there a safe dosage?] |
Search more.